Healios K.K. | Key People and Executives
Tadahisa Kagimoto
Executive President & Representative Director
Ken Ishikawa
Director & Head-Regional Administration
David W. Smith
Outside Director
Richard Patrick Kincaid
Independent Outside Director
Gregory A. Bonfiglio
Independent Outside Director
Yoshinari Matsuda
Director
Michael J. Alfant
Independent Outside Director
Tadahisa Kagimoto
President & Representative Director
Kouichi Tamura
Director, Head-Research & Production Area
Ken Ishikawa
Head-Administration & Investor Relations Contact
Michihisa Nishiyama
Director & Head-Domestic Development
Masanori Sawada
Senior MD & Manager-Business Development
Al Reaves
Director & Manager-Global Development
David W. Smith
Outside Director
Richard Patrick Kincaid
Director
Gregory A. Bonfiglio
Director
Yoshinari Matsuda
Managing Director
Michael J. Alfant
Independent Director
| Address |
World Trade Center Building, 15/F
Tokyo Tokyo 105
Japan
|
|
Employees
|
- |
| Website |
http://www.healios.co.jp |
| Updated |
07/08/2019 |
| Healios KK engages in the development and sale of ophthalmological surgery adjuvants. It aims to commercialize pharmaceutical hiPSC derived retinal pigment epithelium (RPE) cell transplantation for the treatment of age-related macular degeneration. The firm develops therapies for the regeneration of retinal function and to improve visual function in those affected with retinal degenerative diseases. |
